Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 49% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
DelrayResearch.com is also looking into these tickers DAWN, COGT, RMD, BSX, RACE, RTX.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Summary: Decibel Therapeutics is a clinical-stage biotechnology company. It engages in discovering and developing transformative treatments to restore and improve hearing and balance. Decibel Therapeutics is based in BOSTON.
Recent DBTX Stock Price (approx 10:00am EST.): $4.30
Previous Close for DBTX Stock: $4.12
Percentage Price Change Past 10 Days for DBTX stock: +79%
TipRanks.com reports that Decibel Therapeutics stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for DBTX stock with an average price target is $19.67.
Click here to get the full story on DBTX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: C4 Therapeutics Inc. is a biopharmaceutical company. It is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. C4 Therapeutics Inc. is based in WATERTOWN, Mass.
Recent CCCC Stock Price (approx 10:00am EST.): $8.38
Previous Close for CCCC Stock: $8.03
Percentage Price Change Past 10 Days for CCCC stock: +50%
TipRanks.com reports that C4 Therapeutics stock currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for CCCC stock with an average price target is $27.89.
Click here to get the full story on CCCC stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer.
Recent AVEO Stock Price (approx 10:00am EST.): $7.04
Previous Close for AVEO Stock: $6.71
Percentage Price Change Past 10 Days for AVEO stock: +49%
TipRanks.com reports that AVEO Pharma stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for AVEO stock with an average price target is $14.67.
Click here to get the full story on AVEO stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
Click here to join thousands of investors who have already signed up for a free subscription to consumer staples stocks newsletter PoliticsAndMyPortfolio.com.